Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
special purpose acquisition company
Biotech
JATT mastermind launches latest biotech-focused SPAC in $60M IPO
Just two months after Someit Sidhu, M.D., succeeded in pairing off his second SPAC with Talawar Therapeutics, the biotech entrepreneur is back at it.
James Waldron
Aug 26, 2026 9:45am
RA Capital launches Oak Hill Bio onto the Nasdaq via SPAC
Jul 27, 2026 3:25pm
Talawar heads to Nasdaq via SPAC deal to fund eczema bispecific
Jun 29, 2026 7:00am
Preclinical stem cell biotech takes SPAC route to Nasdaq
Feb 4, 2026 10:15am
Freenome to go public in $330M SPAC deal
Dec 5, 2025 10:35am
Singapore drug discovery platform heads to Nasdaq via SPAC deal
Oct 2, 2025 9:50am
